Clinical trial

Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment

NCT01099618

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-03-01

PhasePHASE4

Study timeline

Study start (unknown)2010-03-01Date precision: month

Registry last updated2015-06-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ketosis Prone Diabetesunresolved

Diabetes Ketoacidosisunresolved

Hyperglycemiaunresolved

Interventions

metforminDRUG · verified · RxNorm: metformin

placeboDRUG

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sponsors & collaborators

Dawn Smiley MDlead sponsor

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01099618 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.